Literature DB >> 9315093

High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation.

A Bounacer1, R Wicker, B Caillou, A F Cailleux, A Sarasin, M Schlumberger, H G Suárez.   

Abstract

A high frequency (about 60%) of ret rearrangements in papillary thyroid carcinomas of children exposed to radioactive fallout in Belarus after the Chernobyl accident, has been reported by three recent studies (Fugazzola et al., 1995; Ito et al., 1994; Klugbauer et al., 1995). These studies suggested that the radiation exposure may be a direct inducer of activating rearrangements in the ret gene. In order to confirm the postulated link between irradiation and the role of the ret proto-oncogene in thyroid tumorigenesis, we analysed for the presence of ret activating rearrangements using RT-PCR, XL-PCR, Southern blot and direct sequencing techniques, 39 human thyroid tumors (19 papillary carcinomas and 20 follicular adenomas), from patients who had received external radiation for benign or malignant conditions. As controls, we studied 39 'spontaneous' tumors (20 papillary carcinomas and 19 follicular adenomas). Our data concerning the radiation-associated tumors, showed that: (1) the overall frequency of ret rearrangements was 84% in papillary carcinomas (16/19) and 45% (9/20) in follicular adenomas; (2) in contrast with the results obtained in the Chernobyl tumors, the most frequently observed chimeric gene was RET/PTC1 instead of the RET/PTC3 and (3) all the tumors were negative for RET/PTC2. In the 'spontaneous' tumors, only the papillary carcinomas presented a ret rearrangement (15%:3/20): 1 RET/PTC1, 1 RET/ PTC3 and 1 uncharacterized. In conclusion, our results confirm the crucial role played by the ret proto-oncogene activating rearrangements in the development of radiation-associated thyroid tumors appearing after therapeutic or accidental ionizing irradiation, and show, for the first time, the presence of RET/PTC genes in follicular adenomas appeared after external irradiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315093     DOI: 10.1038/sj.onc.1200206

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  57 in total

Review 1.  Pax-8-PPAR-γ fusion protein in thyroid carcinoma.

Authors:  Priyadarshini Raman; Ronald J Koenig
Journal:  Nat Rev Endocrinol       Date:  2014-07-29       Impact factor: 43.330

2.  RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics.

Authors:  Rebecca J Leeman-Neill; Alina V Brenner; Mark P Little; Tetiana I Bogdanova; Maureen Hatch; Liudmyla Y Zurnadzy; Kiyohiko Mabuchi; Mykola D Tronko; Yuri E Nikiforov
Journal:  Cancer       Date:  2013-02-21       Impact factor: 6.860

Review 3.  RET revisited: expanding the oncogenic portfolio.

Authors:  Lois M Mulligan
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

4.  The effect of cervical X-irradiation on activity index of thyrocytes and plasma TSH: a pre-clinical model for radiation-induced thyroid damage.

Authors:  H M van Santen; J E Van Dijk; H Rodermond; F Vansenne; N Meertens; J Haveman; E Endert; J J M De Vijlder; T Vulsma
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

5.  ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer.

Authors:  Rebecca J Leeman-Neill; Lindsey M Kelly; Pengyuan Liu; Alina V Brenner; Mark P Little; Tetiana I Bogdanova; Viktoria N Evdokimova; Maureen Hatch; Liudmyla Y Zurnadzy; Marina N Nikiforova; Ning J Yue; Miao Zhang; Kiyohiko Mabuchi; Mykola D Tronko; Yuri E Nikiforov
Journal:  Cancer       Date:  2013-12-10       Impact factor: 6.860

6.  Array comparative genomic hybridisation analysis of gamma-irradiated human thyrocytes.

Authors:  Stephen P Finn; Paul Smyth; Esther O'regan; Susanne Cahill; Richard Flavin; John O'leary; Orla Sheils
Journal:  Virchows Arch       Date:  2004-07-17       Impact factor: 4.064

7.  Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas.

Authors:  Alexander Drilon; Lu Wang; Adnan Hasanovic; Yoshiyuki Suehara; Doron Lipson; Phil Stephens; Jeffrey Ross; Vincent Miller; Michelle Ginsberg; Maureen F Zakowski; Mark G Kris; Marc Ladanyi; Naiyer Rizvi
Journal:  Cancer Discov       Date:  2013-03-26       Impact factor: 39.397

8.  Thyroid cancer: current molecular perspectives.

Authors:  Francesca Giusti; Alberto Falchetti; Francesco Franceschelli; Francesca Marini; Annalisa Tanini; Maria Luisa Brandi
Journal:  J Oncol       Date:  2010-03-29       Impact factor: 4.375

9.  ret/PTC activation is not associated with individual radiation dose estimates in a pilot study of neoplastic thyroid nodules arising in Russian children and adults exposed to Chernobyl fallout.

Authors:  R Michael Tuttle; Yvonne Lukes; Lynn Onstad; Eugeni Lushnikov; Alexander Abrosimov; Vladislav Troshin; Anatoli Tsyb; Scott Davis; Kenneth J Kopecky; Gary Francis
Journal:  Thyroid       Date:  2008-08       Impact factor: 6.568

Review 10.  Mechanisms of chromosomal rearrangements in solid tumors: the model of papillary thyroid carcinoma.

Authors:  Manoj Gandhi; Viktoria Evdokimova; Yuri E Nikiforov
Journal:  Mol Cell Endocrinol       Date:  2009-09-18       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.